Cargando…

P1408: UPDATED RESULTS OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) CD22+ B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)

Detalles Bibliográficos
Autores principales:	Boissel, Nicolas, Chevallier, Patrice, Curran, Kevin, Schiller, Gary, Liu, Hongtau, Larson, Richard, Deangelo, Daniel J., Mear, Jean-Baptiste, Grupp, Stephan, Baruchel, André, Konopleva, Marina, Lacroce, Alexandra, Roudet, Caroline, Korngold, Ana, Newhall, Katie, Laille, Eric, Lee, Daniel, Frattini, Mark, Jain, Nitin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430638/ http://dx.doi.org/10.1097/01.HS9.0000972520.32337.3f

Ejemplares similares

P1451: PRELIMINARY RESULTS FROM THE FLU/CY/ALEMTUZUMAB ARM OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) CD22+ B-CELL ALL
por: Jain, N., et al.
Publicado: (2022)

Balli and dramatic madrigals
por: Monteverdi, Claudio, 1567-1643
Publicado: (1991)

miR-22 in tumorigenesis
por: Song, Su Jung, et al.
Publicado: (2014)

P1420: PRE-CLINICAL PROOF OF CONCEPT DEMONSTRATES ROBUST ACTIVITY OF UCART20X22 DUAL CAR T-CELLS FOR THE TREATMENT OF B-CELL MALIGNANCIES
por: Aranda Orgilles, B., et al.
Publicado: (2022)

Modulation of CD22 Protein Expression in Childhood Leukemia by Pervasive Splicing Aberrations: Implications for CD22-Directed Immunotherapies
por: Zheng, Sisi, et al.
Publicado: (2022)

Cryopreserved anti-CD22 and bispecific anti-CD19/22 CAR T cells are as effective as freshly infused cells
por: Dreyzin, Alexandra, et al.
Publicado: (2022)

Targeting IL-22 and IL-22R protects against experimental osteoarthritis
por: Yi, Changhua, et al.
Publicado: (2020)

M. Bally on the Therapeutic Effects of Morphine
Publicado: (1830)

Identification of CD22 Ligands on Bone Marrow Sinusoidal Endothelium Implicated in CD22-dependent Homing of Recirculating B Cells
por: Nitschke, Lars, et al.
Publicado: (1999)

Identification and Quantification by NMR Spectroscopy of the 22R and 22S Epimers in Budesonide Pharmaceutical Forms
por: Kuz’mina, Natalia E., et al.
Publicado: (2022)

A novel full-human CD22-CAR T cell therapy with potent activity against CD22(low) B-ALL
por: Tan, Yue, et al.
Publicado: (2021)

Clinical Pharmacology and Determinants of Response to UCART19, an Allogeneic Anti-CD19 CAR-T Cell Product, in Adult B-cell Acute Lymphoblastic Leukemia
por: Dupouy, Sandra, et al.
Publicado: (2022)

Targeting CD22 for the Treatment of B-Cell Malignancies
por: Shah, Nikesh N, et al.
Publicado: (2021)

Targeting CD22 for B-cell hematologic malignancies
por: Xu, Jia, et al.
Publicado: (2023)

Efficacy and safety of CD22-specific and CD19/CD22-bispecific CAR-T cell therapy in patients with hematologic malignancies: A systematic review and meta-analysis
por: Li, Lili, et al.
Publicado: (2022)

(22E,24R)-5α-Ergosta-2,22-dien-6-one
por: Sheng, Liu-qing, et al.
Publicado: (2011)

IL22/IL-22R Pathway Induces Cell Survival in Human Glioblastoma Cells
por: Akil, Hussein, et al.
Publicado: (2015)

Compound phenotype in a girl with r(22), concomitant microdeletion 22q13.32-q13.33 and mosaic monosomy 22
por: Kashevarova, Anna A., et al.
Publicado: (2018)

The inhibition role of miR-22 in hepatocellular carcinoma cell migration and invasion via targeting CD147
por: Luo, Ling-Juan, et al.
Publicado: (2017)

The Protein Tyrosine Phosphatase Nonreceptor 22 (PTPN22) R620W Functional Polymorphism in Psoriasis
por: Bin Huraib, Ghaleb, et al.
Publicado: (2018)

Inhibition of the B Cell by CD22: A Requirement for Lyn
por: Smith, Kenneth G.C., et al.
Publicado: (1998)

Molecular basis of human CD22 function and therapeutic targeting
por: Ereño-Orbea, June, et al.
Publicado: (2017)

N-Linked Glycosylation Regulates CD22 Organization and Function
por: Wasim, Laabiah, et al.
Publicado: (2019)

Upregulation of CD22 by Chidamide promotes CAR T cells functionality
por: Yang, Xin, et al.
Publicado: (2021)

Anti-CD22/CD20 Bispecific Antibody with Enhanced Trogocytosis for Treatment of Lupus
por: Rossi, Edmund A., et al.
Publicado: (2014)

The Ligand-binding Domain of CD22 Is Needed for Inhibition of the B Cell Receptor Signal, as Demonstrated by a Novel Human CD22-specific Inhibitor Compound
por: Kelm, Soerge, et al.
Publicado: (2002)

The Bs20x22 anti-CD20-CD22 bispecific antibody has more lymphomacidal activity than do the parent antibodies alone
por: Tuscano, Joseph M., et al.
Publicado: (2011)

CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice
por: Matsubara, Naoko, et al.
Publicado: (2018)

Loss of CD22 expression and expansion of a CD22(dim) subpopulation in adults with relapsed/refractory B-lymphoblastic leukaemia after treatment with Inotuzumab-Ozogamicin
por: Reinert, Jochim, et al.
Publicado: (2021)

Run 71, 22 GeV, Ring 1, FS 22, 22.00 - 22.40
por: Keil, Eberhard
Publicado: (1971)

Optimal Clearing Conditions, Run 119, 22 GeV, 20 b, R1, 22 FB
por: Gröbner, Oswald
Publicado: (1971)

Run 265 - 22 GeV/c - 4 bunches - WL 2C22 - R1
por: Vos, L
Publicado: (1972)

Increased frequency of circulating Tc22/Th22 cells and polyfunctional CD38(−) T cells in HIV-exposed uninfected subjects
por: Oliveira, Luanda M. S., et al.
Publicado: (2015)

CD28 Autonomous Signaling Orchestrates IL-22 Expression and IL-22-Regulated Epithelial Barrier Functions in Human T Lymphocytes
por: Kunkl, Martina, et al.
Publicado: (2020)

Decidual Interleukin-22-Producing CD4+ T Cells (Th17/Th0/IL-22+ and Th17/Th2/IL-22+, Th2/IL-22+, Th0/IL-22+), Which Also Produce IL-4, Are Involved in the Success of Pregnancy
por: Logiodice, Federica, et al.
Publicado: (2019)

Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22
por: Qin, Haiying, et al.
Publicado: (2018)

Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes
por: Fiorina, Paolo, et al.
Publicado: (2008)

Targeting CD22 as a strategy for treating systemic autoimmune diseases
por: Dörner, Thomas, et al.
Publicado: (2007)

IL-21 induces IL-22 production in CD4+ T-cells
por: Yeste, Ada, et al.
Publicado: (2014)

Agile CD22 nanoclusters run rings around fenced BCR
por: Depoil, David, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q4jj9kjq1jkd00fd9g3r33qkrc